Vol. 8, 2023

Novelties in Covid-19 research


Violeta Ilić Todorović, Jasmina Jovanović Mirković, Christos Alexopoulos, Momčilo Todorović, Nemanja Nenezić, Zorica Kaluđerović

Pages: 40-44

DOI: 10.37392/RapProc.2023.09

In addition to the traditional role of pharmacists in the preparation, distribution and dispensing of medicines, today pharmacists represent an important link in the health system with their active participation in health promotion and prevention of many diseases. There are a number of educational activities of pharmacists aimed at familiarizing the population with the importance of a healthy lifestyle and risk factors for the development of diseases. Self-medication is defined as the application of drugs for the treatment of symptoms and diseases that the patient himself recognizes. Self-medication is the primary resource of any healthcare system. However, only with adequate, professional advice from pharmacists, who can identify, prevent and solve problems related to self-medication, an optimal and safe outcome of therapy can be achieved, as well as improving the quality of life of patients. The aim and tasks of the research work. Monitoring the consumption of the following OTC preparations: zinc, selenium, vitamins C and D, Paracetamol, Naphazoline, Xylometazoline and Ibuprofen (of 200, 400, 600 mg) immediately before the COVID-19 pandemic, during the COVID-19 pandemic and immediately after. Methodology of the research work. A cross-sectional study was applied before the declaration of the COVID-19 pandemic and after the COVID-19 pandemic. The data source was the electronic prescription database (POINTER 2023) of the “Zdravlje 1” pharmacy in Despotovac. The study lasted 4 years (from 01.01.2019 to 31.12.2022). The data were calculated in the SPSS statistics 20 program package and are presented graphically. Results and discussion. By far the highest consumption is for Ibuprofen 400 mg, followed by Ibuprofen 600 mg, while the lowest consumption for the four-year period from 2019-2022 was for Ibuprofen 200 mg. Observed for each year individually, it was noted that the use of Ibuprofen 200 mg during the outbreak of COVID-19 (2020) showed a drastic increase, five times higher values on an annual basis compared to the time period before and after the occurrence of COVID-19. Conclusion. Taking into account the four-year period of supplementation with zinc, selenium, vitamin D and C also shows an increase in the consumption and use of these supplements for the time period of 2020 and 2021, so that in 2022 there will be a reduction in the use and sale of these OTC preparations.
  1. D. Galato, L. M. Galafassi, G. M. Alano, S. C. Trauthman, “Responsible self-medication: Review of the process of pharmaceutical attendance,” Braz. J. Pharm. Sci., vol. 45, no. 4, pp. 625 – 633, Dec. 2009.
    DOI: 10.1590/S1984-82502009000400004
  2. K. Wilbur, S. E. Salam, E. Mohammadi, “Patient perceptions of pharmacist roles in guiding self-medication of over-the-counter therapy in Qatar,” Patient Prefer. Adherence, vol. 4, no. 3, pp. 87 – 93, May 2010.
    DOI: 10.2147/ppa.s9530
    PMid: 20517469
    PMCid: PMC2875718
  3. E. A. Chrischilles, J. H. Lemke, R. B. Wallace, G. A. Drube, “Prevalence and characteristics of multiple analgesic drug use in an elderly study group,” J. Am. Geriatr. Soc.,vol. 38, no. 9, pp. 979 – 984, Sep. 1990.
    DOI: 10.1111/j.1532-5415.1990.tb04419.x
    PMid: 2212451
  4. A. Blenkinsopp, C. Bradley, “Patients, society, and the increase in self-medication,” BMJ,vol. 312, no. 7031, pp. 629 – 632, Mar. 1996.
    DOI: 10.1136/bmj.312.7031.629
    PMid: 8595343
    PMCid: PMC2350384
  5. M. J. Sculpher, I. Watt, A. Gafni, “Shared decision making in a publicly funded health care system,” BMJ,vol. 319, no. 7212, pp. 725 – 726, Sep. 1999.
    DOI: 10.1136/bmj.319.7212.725
    PMid: 10487985
    PMCid: PMC1116585
  6. G. S. Lau, K. K. Lee, C. T. Luk, “Self-medication among university students in Hong Kong,” Asia Pac. J. Public Health, vol. 8, no. 3, pp. 153 – 157, Jul. 1995.
    DOI: 10.1177/101053959500800301
    PMid: 10050180
  7. S. I. Sharif, O. H. M. Ibrahim, L. Mouslli, R. Waisi, “Evaluation of Self-Medication among Pharmacy Students,” Am. J. Pharmacol. Toxicol. , vol. 7, no. 4, pp. 135 – 140, Dec. 2012.
    DOI: 10.3844/ajptsp.2012.135.140
  8. S. A. Sallam, N. M. Khallafallah, N. K. Ibrahim, A. O. Okasha, “Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt,” East. Mediterr. Health J., vol. 15, no. 3, pp. 683 – 691, May 2009.
    PMid: 19731784
  9. C. L. Lam, M. G. Catarivas, C. Munro, I. J. Lauder, “Self-medication among Hong Kong Chinese,” Soc. Sci. Med.,vol. 39, no. 12, pp. 1641 – 1647, Dec. 1994.
    DOI: 10.1016/0277-9536(94)90078-7
    PMid: 7846561
  10. N. Morrow, O. Hargie, H. Donnelly, C. Woodman, ““Why do you ask?” A study of questioning behaviour in community pharmacist-client consultations” Int. J. Pharm. Pract., vol. 2, no. 2, pp. 90 – 94, Jul. 1993.
    DOI: 10.1111/j.2042-7174.1993.tb00732.x
  11. P. B. Richman, G. Garra, B. Eskin, A. H. Nashed, R. Cody, “Oral Antibiotic Use without Consulting a Physician: A Survey of ED Patients,” Am. J. Emerg. Med. , vol. 19, no 1, pp. 57 – 60, Jan. 2001.
    DOI: 10.1053/ajem.2001.20035
    PMid: 11146021
  12. H. James, S. S. Handu, K. A. J. Al-Khaja, R. P. Sequeira, “Influence of medical training on self-medication by students,” Int. J. Clin. Pharmacol. Ther. , vol. 46, no. 1, pp. 23 – 29, Jan. 2008.
    DOI: 10.5414/cpp46023
    PMid: 18218294
  13. F. R Chang, P. K. Trivedi, “Economics of self‑medication: Theory and evidence,” Health Econ., vol. 12, no. 9, pp. 721 ‑ 739, Sep. 2003.
    DOI: 10.1002/hec.841
    PMid: 12950092
  14. J. R. Laporte, “Automedicación: la información de los usuarios aumenta al mismo tiempo que el consumo?,” Med. Clin. (Barc)., vol. 109, no. 20, pp. 795 ‑ 796, Dec. 1997.
    (J. R. Laporte, “Self‑medication: Does information to users increase at the same rate as consumption,” Med. Clin. (Barc)., vol. 109, no. 20, pp. 795 ‑ 796, Dec. 1997.)
    PMid: 9493159
  15. M. E. Ruiz, “Risks of self‑medication practices,” Curr. Drug Saf., vol. 5, no. 4, pp. 315 ‑ 323, Oct. 2010.
    DOI: 10.2174/157488610792245966
    PMid: 20615179
  16. M. A. Flaiti, K. A. Badi, W. O. Hakami, S. A. Khan, “Evaluation of self-medication practices in acute diseases among university students in Oman,” J. Acute Dis., vol. 3, no. 3, pp. 249 – 252, 2014.
    DOI: 10.1016/S2221-6189(14)60056-1
  17. J. S. Mogil, “Sex differences in pain and pain inhibition: Multiple explanations of a controversial phenomenon,” Nat. Rev. Neurosci., vol. 13, no. 12, pp. 859 – 866, Dec. 2012.
    DOI: 10.1038/nrn3360
    PMid: 23165262